BIOPHARMA CREDIT PLC

FTSE Russell Analytics

PDF, 466.82KB, 4 pages

Share price analysis relative to sector and index performance.

Company tear sheet

PDF, 53.94KB, 7 pages

Full issuer details available in a single file ready for sharing.

161 results (20 showing)

Headline	Source	Date	Time
Net Asset Value(s) RNS 20 September 2019 16:00:03	RNS	20.09.19	16:00:03
New Investment RNS 13 September 2019 07:00:04	RNS	13.09.19	07:00:04
Half-year Report RNS 04 September 2019 07:00:04	RNS	04.09.19	07:00:04
Update on Investment RNS 11 September 2019 17:10:02	RNS	11.09.19	17:10:02
Notice of Interim Results RNS 12 August 2019 07:00:07	RNS	12.08.19	07:00:07
Net Asset Value(s) RNS 19 July 2019 16:00:01	RNS	19.07.19	16:00:01
NOTICE OF FULL YEAR RESULTS RNS 27 February 2019 10:40:01	RNS	27.02.19	10:40:01
Dividend Declaration RNS 21 February 2019 17:00:03	RNS	21.02.19	17:00:03
Net Asset Value(s) RNS 21 February 2019 16:00:04	RNS	21.02.19	16:00:04
Net Asset Value(s) RNS 22 January 2019 16:00:05	RNS	22.01.19	16:00:05
Annual Financial Report RNS 05 March 2019 07:00:05	RNS	05.03.19	07:00:05
STATEMENT RE TESARO RNS 22 January 2019 16:00:05	RNS	22.01.19	16:00:05
Net Asset Value(s) RNS 21 December 2018 16:00:00	RNS	21.12.18	16:00:00
Appointment of Director RNS 06 December 2018 07:00:10	RNS	06.12.18	07:00:10
STATEMENT RE TESARO RNS 04 December 2018 07:00:12	RNS	04.12.18	07:00:12
Net Asset Value(s) RNS 21 November 2018 16:00:05	RNS	21.11.18	16:00:05
Holding(s) in Company RNS 14 November 2018 15:00:01	RNS	14.11.18	15:00:01
Holding(s) in Company RNS 07 November 2018 14:30:01	RNS	07.11.18	14:30:01
Holding(s) in Company RNS 07 November 2018 14:30:01	RNS	07.11.18	14:30:01
Holding(s) in Company RNS 07 November 2018 14:30:01	RNS	07.11.18	14:30:01